SHIELD

Simulation of High-risk patients for Empowerment, Learning, and Disease Management

Suitable for General practitioners and Hospital Care Physicians

Price: available upon request

If you have a coupon code, add this product to the cart to redeem it.

SKU: SHIELD Categories: ,
Course type: Online; Self-Paced
Duration: Available for 2 months
Modules: 10
Time required: Up to 2 hour per module
Target Audience: General Practitioner and Hospital Care Physicians
Specialty: Cardiology/Endocrinology
Level: Intermediate to Advanced
Language: English; Portuguese
Certificate: Yes

About the SHIELD – Simulation of High-risk patients for Empowerment, Learning and Disease Management

SHIELD is an innovative and interactive training program that explores the primary and hospital care physicians’ role in cardiovascular risk and diabetes management.

This practice-based activity provides an update on the latest guidelines and novel approaches to global cardiovascular protection.

The SHIELD course allows to educate primary and hospital care physicians and on current evidence-based treatment goals and most recent clinical management recommendations for high-risk cardiovascular and diabetic patients.

Target Audience

Recommended for General Practitioner and Hospital Care Physicians

Course Overview

10 Modules
The course consists of 10 modules with virtual patient cases, with an intermediate and advanced level of complexity.
Average Time to practice (per module)
• Clinical Scenario: 20 minutes per attempt (3 attempts: 60 minutes)
• Final attempt (if applicable): 20 minutes
• Multiple Choice Question: 5 minutes
• Feedback Area: 10 minutes
• Learning Objectives and Scientific References: 10 minutes
• Debriefing Videos: 5 minutes
Online, Self-paced
You have up to 3 months to complete the 10 modules at your own pace.
Certificate of Completion
After completing the course, you will be given a Certificate of Completion.

What you will learn:

By undertaking this course, the physicians will be prepared to:

  • Understand the role of SLT2 inhibitors in the treatment and cardioprotection of diabetic, cardiac insufficiency, and renal insufficiency patients.
  • Optimize the estimation of cardiovascular risk in diabetic patients with cardiac insufficiency and renal insufficiency and promote its reduction using the best available pharmacological therapy
  • Identify and manage potential side effects of cardioprotective medication in these patient populations
Enroll now!

Meet the Course Director

Professor Pedro Monteiro responsible for Body Interact course - CHeFS

Professor Pedro Monteiro

MD, PhD

Faculty of Medicine, University of Coimbra, Portugal
Cardiology Consultant - Coimbra University Hospital

Course Outline

Module 1 - A routine appointment with some lab abnormalities

Context: More than a metabolic disease, diabetes is an important cardiovascular risk factor with a very adverse prognostic impact. Throughout its natural history, it is important to simultaneously optimize antibiotic and cardioprotective therapy and identify and control all cardiovascular risk factors. When diagnosing diabetes, starting cardioprotective antidiabetic therapy is vital to ensure the best possible prognosis.

Virtual Scenario: Mr. Joshua has been struggling to stop smoking for over 10 years and has also a past medical history of hypertension and dyslipidemia.

After concluding this module, please fill out the survey

Module 2 - Routine appointment with complaints of fatigue when doing hard work

Context: More than a metabolic disease, diabetes is an important cardiovascular risk factor with a very adverse prognostic impact. Throughout its natural history, it is important to simultaneously optimize antibiotic and cardioprotective therapy and identify and control all cardiovascular risk factors. When monotherapy is not enough, it is important to choose the best cardioprotective antidiabetic therapy.

Virtual Scenario: Ms. Voight has a medical history of type 2 diabetes, hypertension, and dyslipidemia.

After concluding this module, please fill out the survey

Module 3 - Is normal is always normal?

Context: More than a metabolic disease, diabetes is an important cardiovascular risk factor with a very adverse prognostic impact. Throughout its natural history, it is important to simultaneously optimize antibiotic and cardioprotective therapy and identify and control all cardiovascular risk factors. When dual therapy is not enough, it is important to reinforce it with the best cardioprotective antidiabetic therapy.

Virtual Scenario: Mr. Godier was diagnosed with diabetes eight years ago. Since then, he is regularly visiting a doctor to check his health.

After concluding this module, please fill out the survey

Module 4 - When three is to many but not enough

Context: More than a metabolic disease, diabetes is an important cardiovascular risk factor with a very adverse prognostic impact. Throughout its natural history, it is important to simultaneously optimize antibiotic and cardioprotective therapy and identify and control all cardiovascular risk factors. Even in patients already insulin-treated, whenever metabolic control is not perfect, it makes sense to consider a reinforcement of oral cardioprotective therapy.

Virtual Scenario: Mrs. Hudson is retired and loves to take care of her grandchildren during the week. She has had diabetes for over 11 years but she has never managed to control her sugar levels. Additionally, she has hypertension and dyslipidemia.

After concluding this module, please fill out the survey

Module 5 - A patient with de novo fatigue and dyspnea

Context: The new ESC guidelines represent a change of paradigm in the treatment of heart failure, which now has four pillars regarding drug therapy. In each heart failure patient, our goal is now to introduce these four drugs in the optimal doses as soon as possible to improve patient prognosis. This means adding a SGLT2 inhibitor in all patients eligible.

Virtual Scenario: Mr. Liu has recently retired from his job. He has been losing his energy with small efforts at home, going up and down the stairs. He has also a medical history of alcoholism and smoking.

After concluding this module, please fill out the survey

Module 6 - I keep getting tired and short of breath. Can you help me?

Context: The new ESC guidelines represent a change of paradigm in the treatment of heart failure, which now has four pillars regarding drug therapy. In each heart failure patient, our goal is now to introduce these four drugs in the optimal doses as soon as possible to improve patient prognosis. In many heart failure patients, conventional therapy will not be enough, thus requiring new optimal therapy.

Virtual Scenario: Ms. Wilkins hasn’t been feeling well lately. Daily tasks seem to leave her without any energy, even before completing them. A family member recommended she see a doctor, which is why she is here at the clinic.

After concluding this module, please fill out the survey

Module 7 - I take several meds but I keep feeling tired. What’s wrong with me?

Context: The new ESC guidelines represent a change of paradigm in the treatment of heart failure, which now has four pillars regarding drug therapy. In each heart failure patient, our goal is now to introduce these four drugs in the optimal doses as soon as possible to improve patient prognosis. In many heart failure patients, triple therapy will not be enough, thus requiring the fourth pillar.

Virtual Scenario: Mr. Reed really enjoys socializing with his friends. He has dinner with his friends every week, but at his last dinner, his colleagues noticed that he felt very tired and with shortness of breath when he made small efforts. They talked to him and he made a routine appointment.

After concluding this module, please fill out the survey

Module 8 - Swollen eyes and orange urine

Context: Recent studies promote a change of paradigm in the treatment of kidney failure, which now has three pillars regarding drug therapy. In each kidney failure patient, our goal is now to introduce these drugs in the optimal doses as soon as possible to improve patient prognosis. It should be done as soon as a diagnosis of kidney failure is done.

Virtual Scenario: Mr. Akiyama was progressively urinating less during the past couple of years. At first, he didn’t notice anything odd with the frequency he went to the bathroom. However, as this situation progressed, he couldn’t ignore the problem anymore and scheduled a visit at the clinic.

After concluding this module, please fill out the survey

Module 9 - Kidneys and Pancreas: a deadly duet

Context: Recent studies promote a change of paradigm in the treatment of kidney failure, which now has three pillars regarding drug therapy. In each kidney failure patient, our goal is now to introduce these drugs in the optimal doses as soon as possible to improve patient prognosis. One of these drugs can be used not only for kidney protection but also for cardiovascular and metabolic optimization

Virtual Scenario: Ms. Kamau has had diabetes for several years. Unfortunately, she has not paid much attention to the doctor’s advice, which has not helped control her blood glucose levels. Lately, she has been feeling ill and decided to see her doctor.

After concluding this module, please fill out the survey

Module 10 - Chronic renal failure and HTA without diabetes under ARB and CCB

Context: Recent studies promote a change of paradigm in the treatment of kidney failure, which now has three pillars regarding drug therapy. In each kidney failure patient, our goal is now to introduce these drugs in the optimal doses as soon as possible to improve patient prognosis. In patients using only classical therapy, the adding of a third drug can vastly improve kidney function and patient prognosis.

Virtual Scenario: Mr. Alexandersson is a senior with a tendency for high blood pressure. He has felt that his health is not as robust as it used to be, so he reluctantly accepted his wife’s insistence to see a doctor.

After concluding this module, please fill out the survey
Body Interact is ready for multiple devices

After acquiring this course, you can access it through the Body Interact app at any time:

Body Interact Web Version

If you are not familiar with Body Interact, visit our Help Center for FAQs and tutorial videos.